ECONOMIC EVALUATION OF BEVACIZUMAB VERSUS RANIBIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CHINA

被引：0
|
作者：
Li, H. [1 ]
Li, X. [2 ]
Xie, F. [3 ]
机构：
[1] China Pharmaceut Univ, Nanjing, Jiangsu, Peoples R China
[2] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
[3] McMaster Univ, Hamilton, ON, Canada
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.385
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS8
引用
收藏
页码：A782 / A782
页数：1
相关论文
共 50 条
  • [11] Ranibizumab for neovascular age-related macular degeneration
    Hernandez-Pastor, Luis Javier
    Ortega, Ana
    Garcia-Layana, Alfredo
    Giraldez, Joaquin
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (19) : 1805 - 1814
  • [12] Ranibizumab for neovascular age-related macular degeneration
    Gillies, Mark C.
    Wong, Tien Y.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 748 - 749
  • [13] Ranibizumab in neovascular age-related macular degeneration
    Eng, Kenneth T.
    Kertes, Peter J.
    [J]. CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) : 451 - 466
  • [14] Bevacizumab versus ranibizumab for the treatment of neovascular age- related macular degeneration
    Soiberman, Uri
    Loewenstein, Anat
    [J]. EXPERT REVIEW OF OPHTHALMOLOGY, 2010, 5 (05) : 603 - 615
  • [15] Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients
    Jun Li
    Han Zhang
    Peng Sun
    Feng Gu
    Zhe-Li Liu
    [J]. International Journal of Ophthalmology, 2013, (02) : 169 - 173
  • [16] Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients
    Li, Jun
    Zhang, Han
    Sun, Peng
    Gu, Feng
    Liu, Zhe-Li
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2013, 6 (02) : 169 - 173
  • [17] Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
    Martin, Daniel F.
    Maguire, Maureen G.
    Ying, Gui-shuang
    Grunwald, Juan E.
    Fine, Stuart L.
    Jaffe, Glenn J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (20): : 1897 - 1908
  • [18] Bevacizumab for Neovascular Age-Related Macular Degeneration
    Silva, Aline
    Furlan, Luiz
    Elias, Flavia
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 75 - 76
  • [19] Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration
    Biswas, Partha
    Sengupta, Subhrangshu
    Choudhary, Ruby
    Home, Subhankar
    Paul, Ajoy
    Sinha, Sourav
    [J]. INDIAN JOURNAL OF OPHTHALMOLOGY, 2011, 59 (03) : 191 - 196
  • [20] Intravitreal anti-VEGF therapy in neovascular age-related macular degeneration: Bevacizumab versus Ranibizumab
    Zehetner, C.
    Kralinger, M. T.
    Kieselbach, G. F.
    [J]. SPEKTRUM DER AUGENHEILKUNDE, 2008, 22 (06) : 370 - 375
12345